
Randall J. Bateman
Randall J. Bateman, MD, is a prominent neurologist and the Charles F. and Joanne Knight Distinguished Professor of Neurology at Washington University in St. Louis. He is known for his research in Alzheimer's disease, particularly focusing on its genetic aspects and the development of potential treatments. Recently, he was in the news for leading a clinical trial that demonstrated an experimental drug's potential to delay the onset of Alzheimer's symptoms in individuals with a high genetic risk for the disease.
Global Media Ratings
Countries Mentioned
Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
---|---|---|---|---|---|---|---|---|
United States | 1 | 7.00 | 0.03% | +0% | 331,002,651 | 99,341 | $21,000,000 | 6,303$ |
Paraguay | 1 | 8.00 | 0.06% | +0% | 7,132,538 | 4,009 | $38,000 | 21$ |
Bolivia | 1 | 9.00 | 0.06% | +0% | 11,673,021 | 6,915 | $40,000 | 24$ |
Totals | 3 | 349,808,210 | 110,265 | $21,078,000 | 6,348$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
Co-senior author Randall J. Bateman, MD, noted that in clinical practice today, there is not an easy or accessible measure of Alzheimer’s tangles and dementia.
7
Bolivia:
Randall J. Bateman is the principal co-author of the study and a professor at the University of Washington.
9
Paraguay:
Randall J. Bateman is the co-lead author of the study and a professor at the University of Washington.
8
United States:
Senior author Randall J. Bateman, MD, the Charles F. and Joanne Knight Distinguished Professor of Neurology at WashU Medicine, discussed the study's findings.
7